HSR26-227: Post-Allogenic Hematopoietic Stem Cell Transplant (Allo-HSCT), Hypomethylating-Agent Maintenance Improves Survival Without Increasing GVHD (Graft Versus Host Disease) in AML/MDS (Acute Myeloid Leukemia/Myelodysplastic Syndrome): Updated Systematic Review and Meta-Analysis [0.03%]
异基因造血干细胞移植后低甲基化药物维持可改善AML/MDS患者的生存率而不增加移植物抗宿主病：系统评价和meta分析的更新报告
Anubhuti Sharma,Arundhati Sharma,Simranpreet Singh Daid et al.
Anubhuti Sharma et al.
CLO26-120: Vanishing Neutrophils: An Uncommon Complication of Thymomas [0.03%]
CLO26-120：中性粒细胞减少：胸腺瘤的少见并发症
Nathan Keefer,Zalak Shah,Natalie Reed et al.
Nathan Keefer et al.
CLO26-076: Prognostic Outcomes in Resected Pancreatic Cancer Treated With Neoadjuvant Chemotherapy Alone: Impact of Integrated Pathologic Score [0.03%]
内镜下鼻胆管引流与塑料支架治疗良性胆道狭窄的比较：一项随机临床试验
Jin-Ju Lee,Michael Aboujaoude,Adrianna Oraiqat et al.
Jin-Ju Lee et al.
BPI26-028: Hippocrates-Karkinos-o1: An Enhanced Model for Oncology Decision Support and Guideline-Aware Reasoning With Self-Refinement and Guideline-Informed Retrieval [0.03%]
赫尔普克Tes-Karkinos-o1：一种增强的肿瘤决策支持和指南意识推理模型，具有自我完善和基于指南的信息检索功能
Nicole Aguirre,Benlu Wang,Elizabeth Schaefer et al.
Nicole Aguirre et al.
BPI26-029: Analysis of Racial Demographic Reporting in Clinical Studies Supporting the NCCN Esophageal & Esophagogastric Junction Cancer Guidelines [0.03%]
种族人口统计学报告的分析：支持美国国立综合癌症网络食管与食管胃交界部肿瘤指南的临床研究
Adam Bowen,Claire Russell,Ramalakshmi Thulluri et al.
Adam Bowen et al.
CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens [0.03%]
伊法贝格司亭治疗14天化疗周期/密集型方案的真實世界证据数据分析：CLO26-092研究
Lee Schwartzberg,Jeffrey Crawford,John Baird et al.
Lee Schwartzberg et al.
CLO26-119: Clinical Outcomes of Gastric Outlet Obstruction Among Patients With Pancreatic Cancer Stratified by Sex: A Multicenter Analysis Using the Nationwide Readmissions Database (NRD) [0.03%]
基于全国再入院数据库的胰腺癌患者性别的胃出口梗阻临床结局的多中心分析:CLO26-119
Reem Dergham,Tanveer Mir,Sabah Ambreen et al.
Reem Dergham et al.
CLO26-114: Association Between Neoadjuvant Chemoimmunotherapy-Induced Anemia and Survival in Patients With Resectable Non-Small Cell Lung Cancer [0.03%]
CLE26-114：可切除非小细胞肺癌患者新辅助化疗免疫治疗诱导性贫血与生存期之间的关联
Jennifer D Hwang,Po-Lan Su,Sonia Zhao et al.
Jennifer D Hwang et al.
CLO26-091: CPX-351 vs Standard 7 + 3 Chemotherapy in Secondary Acute Myeloid Leukemia and Acute Myeloid Leukemia With Myelodysplasia-Related Changes [0.03%]
CPX-351与标准7+3化疗在继发性急性髓系白血病和伴有骨髓增生异常相关改变的急性髓系白血病中的对比研究
Hamza S Ansari,Bolivia Aloycia Crocete Fernandes,Canan D Dirican et al.
Hamza S Ansari et al.